Latest Administration News

Santana Minerals made significant strides in the June quarter at its Bendigo-Ophir Gold Project, progressing regulatory approvals, expanding mineralisation, and securing robust funding to underpin development plans.

AdAlta has completed a key US$1 million milestone payment securing rights to its lead CAR-T therapy EW-001 outside Greater China, progressed Australian manufacturing with first runs expected late 2026, and is preparing for a critical pre-IND meeting with the US FDA.

Emyria has expanded its Empax clinic network across four states, reporting a 210% revenue increase in FY26 and early clinical success in treatment-resistant depression.

Metal Bank is pushing its Western Australian gold projects closer to production while expanding critical minerals exploration in Queensland, supported by a $1.2 million placement.

Osmond Resources has delivered robust assay results from drill hole SOR-08A and channel samples at its Orión EU Critical Minerals Project, underpinning a maiden Mineral Resource Estimate and a low-capex Scoping Study. The company is also progressing a secondary listing on the Bolsa de Madrid, supported by a fully assembled Spanish team.

Perpetual Limited recorded solid growth across its divisions in Q4 FY26, with Corporate Trust and Asset Management buoyed by market gains despite net outflows. The company is advancing the sale of its Wealth Management arm to Bain Capital, targeting completion in late 2026.

IRIS Metals is gearing up for a substantial tungsten drilling campaign in Montana while delivering a fresh lithium-rubidium resource estimate for its South Dakota project, underpinning its North American critical minerals ambitions.

D3 Energy has expanded its helium resource base significantly in South Africa, certifying a maiden contingent resource at ER386 that boosts combined helium resources by 65%. The company also certified its first Australian prospective resource and started drilling at Nooitgedacht in ER315.

Wildcat Resources made significant strides in its Pilbara lithium projects during the June 2026 quarter, expanding the Tabba Tabba DFS scope and confirming robust metallurgical recoveries at both Tabba Tabba and Bolt Cutter Central. The company ended the quarter with a solid cash position of $37.2 million.

Morella Corporation has kicked off its maiden rubidium Mineral Resource Estimate at Mt Edon following a comprehensive drilling program and final assay results, while strengthening its balance sheet through a A$2.1 million capital raising.

NeuroScientific Biopharmaceuticals achieved an 80% clinical response rate in fistulising Crohn’s disease patients treated under the TGA Special Access Scheme, advancing plans for Phase 2 trials and manufacturing scale-up.

InVert Graphite has acquired RapidGraphite and its RapidPulse™ technology, aiming to revolutionise graphite processing with rapid, acid-free purification. The company raised A$2.5 million to fund scale-up trials and integrate this with its Morogoro graphite project in Tanzania.